AgingResearch.NewsJoin free

BELL Therapeutics

CompanySouth Korea

BELL Therapeutics develops 2 assets, the furthest in human trials (BELL-001 in insomnia). Mostly device; based in South Korea.

2
Assets
Furthest stage
Human trials
1
Trial
3
Signals

Pipeline

2

  • BELL-001

    Synchronizes smartphone-delivered sounds with the user's breathing to influence brain activity and autonomic responses.

    Human trials, Device, insomnia

  • BELL-002

    Digital auditory rehabilitation helps children with cochlear implants understand speech and appreciate music.

    Stage not known, Device

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Signals3
  • Similar companies1

Intelligence